Trillium Asset Management, LLC Amgen Inc Transaction History

Trillium Asset Management, LLC

$4 Billion
Q3 2024

A detailed history of Trillium Asset Management, LLC transactions in Amgen Inc stock. As of the latest transaction made, Trillium Asset Management, LLC holds 874 shares of AMGN stock, worth $228,306. This represents 0.01% of its overall portfolio holdings.

Number of Shares

874

Previous 874 -0.0%

Holding current value

$228,306

Previous $273,000 2.93%

% of portfolio

0.01%

Previous 0.01%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 07, 2024	SELL	$262.75 - $319.31 $17,604 - $21,393	-67 Reduced 7.12%	874 $273,000
Q1 2024 May 09, 2024	SELL	$268.87 - $324.56 $16,938 - $20,447	-63 Reduced 6.27%	941 $267,000
Q3 2023 Nov 07, 2023	SELL	$218.65 - $271.46 $2,623 - $3,257	-12 Reduced 1.18%	1,004 $269,000
Q4 2022 Feb 07, 2023	SELL	$229.03 - $291.01 $2,061 - $2,619	-9 Reduced 0.88%	1,016 $266,000
Q2 2022 Aug 08, 2022	SELL	$230.71 - $256.74 $40,374 - $44,929	-175 Reduced 14.58%	1,025 $249,000
Q1 2022 May 04, 2022	SELL	$219.27 - $242.57 $70,166 - $77,622	-320 Reduced 21.05%	1,200 $290,000
Q4 2021 Feb 08, 2022	SELL	$198.88 - $227.6 $1,392 - $1,593	-7 Reduced 0.46%	1,520 $342,000
Q3 2021 Nov 12, 2021	SELL	$212.27 - $248.7 $45,001 - $52,724	-212 Reduced 12.19%	1,527 $325,000
Q2 2021 Aug 06, 2021	SELL	$233.58 - $259.14 $2,335 - $2,591	-10 Reduced 0.57%	1,739 $424,000
Q3 2020 Nov 09, 2020	SELL	$234.65 - $260.95 $9,620 - $10,698	-41 Reduced 2.29%	1,749 $445,000
Q2 2020 Aug 06, 2020	SELL	$197.81 - $242.74 $219,569 - $269,441	-1,110 Reduced 38.28%	1,790 $422,000
Q4 2019 Feb 10, 2020	SELL	$189.21 - $243.2 $209,266 - $268,979	-1,106 Reduced 27.61%	2,900 $699,000
Q3 2019 Nov 06, 2019	BUY	$174.11 - $208.62 $482,981 - $578,711	2,774 Added 225.16%	4,006 $775,000
Q2 2019 Aug 08, 2019	SELL	$166.7 - $195.41 $4,834 - $5,666	-29 Reduced 2.3%	1,232 $227,000
Q1 2018 May 09, 2018	SELL	$169.43 - $198.0 $68,619 - $80,190	-405 Reduced 24.31%	1,261 $215,000
Q3 2017 Nov 02, 2017	BUY	$167.29 - $191.0 $278,705 - $318,206	1,666	1,666 $311,000

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $140B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Trillium Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Trillium Asset Management, LLC with notifications on news.

Account

Trillium Asset Management, LLC Amgen Inc Transaction History